For instance, a study by Al Amri et al. [8] found that germline BRCA1/2 mutations were not over-represented in early-onset breast cancer (EOBC) cases in Oman, suggesting that Oman is not responsible for high worldwide EOBC rates. This evidence concerns the gene BRCA1 and breast cancer.